Analyst Recommendations

Wells Fargo analyst issues MARKET PERFORM recommendation for OKTA on February 26, 2024 08:01AM ET. The previous analyst recommendation was Market Perform.OKTA was trading at $83.24 at issue...

February 26, 2024   OKTA 0.74%

Wells Fargo analyst issues OVERWEIGHT recommendation for OHI on February 26, 2024 05:24AM ET. OHI was trading at $31.12 at issue of the analyst recommendation.The overall analyst consensus...

February 26, 2024   OHI 1.39%

Wells Fargo analyst issues OVERWEIGHT recommendation for NHI on February 26, 2024 05:24AM ET. The previous analyst recommendation was Equal-Weight.NHI was trading at $57.76 at issue of the...

February 26, 2024   NHI 0.35%

Piper Sandler analyst issues OVERWEIGHT recommendation for CE on February 26, 2024 03:50AM ET. The previous analyst recommendation was Neutral.CE was trading at $149.38 at issue of the...

February 26, 2024   CE -3.29%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for FMCC on February 26, 2024 03:07AM ET. The previous analyst recommendation was Market Perform.FMCC was trading at $1.0701 at...

February 26, 2024   FMCC 0.38%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for ROOT on February 26, 2024 03:07AM ET. The previous analyst recommendation was Market Perform.ROOT was trading at $16.96 at...

February 26, 2024   ROOT 5.44%

HSBC analyst issues BUY recommendation for TT on February 24, 2024 11:48PM ET. The previous analyst recommendation was Hold.TT was trading at $0 at issue of the analyst...

February 26, 2024   TT 0.07%

Wedbush analyst issues OUTPERFORM recommendation for NICE on February 23, 2024 02:39PM ET. The previous analyst recommendation was Outperform.NICE was trading at $238.6 at issue of the analyst...

February 23, 2024   NICE -1.01%

RBC Capital analyst issues OUTPERFORM recommendation for NICE on February 23, 2024 02:39PM ET. The previous analyst recommendation was Outperform.NICE was trading at $238.6 at issue of the...

February 23, 2024   NICE -1.01%

William Blair analyst issues OUTPERFORM recommendation for MRVI on February 23, 2024 02:07PM ET. The previous analyst recommendation was Outperform.MRVI was trading at $8.25 at issue of the...

February 23, 2024   MRVI -2.58%